How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

Organelles are entities within a eukaryotic cell that have a specialised function. Examples of organelles include the nucleus, the endoplasmic reticulum, the Golgi, mitochondria, vacuoles or lysosomes ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Amanda Bellucco-Chatham is an editor, writer, and fact-checker with years of experience ...

Jane Meacham has 40 years' experience researching, writing, and editing financial content. She previously worked at Dow Jones & Co. in the U.S. and Asia, and is certified in Global Reporting ...

Bacteria are microscopic organisms found throughout the world that play important roles in human health, ecosystems, and everyday life, though some types can also cause infections and illness.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...